Mnemo Therapeutics Competitors and Similar CompaniesClear all
Spur Therapeutics's competitors and similar companies include Acorda Therapeutics.
 Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. |  Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. | |
Founding Date | Founding Date 2015 | Founding Date 1995 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Stevenage, GB HQ Boston, US New York, US | Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US |
Employees | Employees 122 | Employees 4742% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $117.6m (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods $15.3m (FY, 2023) |
Net income | Net income ($89m) (FY, 2022) | Net income ($252.9m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Acorda Therapeutics
HQ
Ardsley, US
Employees
474↓ 2% decrease
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
View company